CTV News Calgary: Resverlogix Announces COVID-19 Trial
Following new published evidence of apabetalone's benefit in COVID-19 Resverlogix is announcing the initiation of human clinical trials..
© 2023 Frontier Merchant Capital Group. All Rights Reserved.